ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Charles C. Canver
Charles A.S. Marrin
Stephen K. Plume
William C. Nugent
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canver, C. C.
Right arrow Articles by Nugent, W. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canver, C. C.
Right arrow Articles by Nugent, W. C.

Ann Thorac Surg 1993;55:1202-1204
© 1993 The Society of Thoracic Surgeons


Articles

Should a patient with a treated cancer be offered an open heart operation?

Charles C. Canver, MD*, Charles A.S. Marrin, MB, BS, Stephen K. Plume, MD, William C. Nugent, MD

Section of Cardiothoracic Surgery, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire USA

Accepted for publication September 4, 1992.

* Address reprint requests to Dr Canver, Section of Cardiothoracic Surgery, Dartmouth-Hitchcock Medical Center, One Medical Center Dr, Lebanon NH 03756-0001.

The unknown but presumably reduced life expectancy of patients with malignant neoplasms may dissuade surgeons from performing necessary coronary and valvular heart operations. There is also concern for recrudescence of cancer as a result of an impaired immune system after cardiopulmonary bypass. We analyzed the records of 2,190 patients who underwent cardiac operations requiring extracorporeal circulation between 1988 and 1990. Of these, 46 patients had previously been treated for malignancy other than nonmelanoma skin cancer. Open heart operations were performed in patients with cardiac symptoms only in the absence of tumor recurrence. Tumor staging indicated reduced life expectancy in all patients. Thirty-eight patients (82.7%) had myocardial revascularization; 8 patients (17.3%) underwent valve operations. Postoperatively, all but 2 patients were free from complications. In-hospital mortality was 4.3% ([equation]). One patient died of cardiogenic shock after combined aortic and mitral valve replacement; the second patient succumbed to pulmonary embolism after reoperative coronary artery bypass grafting. Actuarial survival at 3 years was 96%, and all patients reported a satisfactory quality of life. This experience suggests that cardiac operations in selected patients with previously treated cancer are safe and offer clinical improvement at a reasonable operative risk.




This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
W. Dyszkiewicz, M. Jemielity, C. Piwkowski, M. Kasprzyk, B. Perek, L. Gasiorowski, and E. Kaczmarek
The early and late results of combined off-pump coronary artery bypass grafting and pulmonary resection in patients with concomitant lung cancer and unstable coronary heart disease
Eur J Cardiothorac Surg, September 1, 2008; 34(3): 531 - 535.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Erez, S. Eldar, E. Sharoni, D. Abramov, A. Sulkes, and B. A. Vidne
Coronary artery operation in patients after breast cancer therapy
Ann. Thorac. Surg., October 1, 1998; 66(4): 1312 - 1317.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The Society of Thoracic Surgeons.